Last reviewed · How we verify
quadrivalent subunit influenza vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
quadrivalent subunit influenza vaccine (quadrivalent subunit influenza vaccine) — Ab&B Bio-tech Co., Ltd.JS.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| quadrivalent subunit influenza vaccine TARGET | quadrivalent subunit influenza vaccine | Ab&B Bio-tech Co., Ltd.JS | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- quadrivalent subunit influenza vaccine CI watch — RSS
- quadrivalent subunit influenza vaccine CI watch — Atom
- quadrivalent subunit influenza vaccine CI watch — JSON
- quadrivalent subunit influenza vaccine alone — RSS
Cite this brief
Drug Landscape (2026). quadrivalent subunit influenza vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/quadrivalent-subunit-influenza-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab